cheshtasharma

About Cheshta Sharma

This author has not yet filled in any details.
So far Cheshta Sharma has created 1323 blog entries.

Claim terms are not indefinite in Massachusetts Institute of Technology for growing cells

This case involves three dimensional scaffolds for growing cells in vitro for in vivo organ culture holding patent numbers 5,770,193 and 5,759,830. The prior art states that in vitro cell growth for in vivo organ culture was performed using either permanent synthetic polymer scaffolds or biodegradable scaffolds and also limitations exist like variability in degradation of the collagen scaffold also these [...]

By |2017-09-08T17:44:43+05:30November 18th, 2016|IP Basics|0 Comments

Why Aventis sued a case against Lupin?

The fight is for the angiotensin-converting enzyme (ACE) - Ramipril which is used for treating high blood pressure by inhibiting a biochemical pathway that constricts blood vessels. Aventis sued a case against Lupin for filing of ANDA (Abbreviated New Drug Application) for a generic version of the ACE inhibitor Ramipril. According to the summary [...]

By |2017-09-08T17:47:16+05:30November 18th, 2016|Patent|0 Comments

Motorola’s infringement on “Laser direct structuring”

It is interesting to see on how Motorola Is going to handle the cases, and people are waiting to know which path will Motorola choose either recall those infringing devices including the Moto G and Moto X, and remove Moto Maker access from Germany or will they file appeal to fight to patent holder. [...]

By |2017-09-08T17:48:27+05:30November 18th, 2016|Trademark|0 Comments

Patent infringement case filed against Lupin by Horizon pharma for “Pennsaid”

A patent infringement case has been filed against Lupin by Horizon pharma, a US based drugs company. It filed the case in District Court of New Jersey for asserting its rights over four patents for the manufacture of a non-steroidal anti-inflammatory drug called Pennsaid which contains two per cent of diclofinac sodium. Lupin has [...]

By |2017-09-08T17:49:57+05:30November 18th, 2016|Patent|0 Comments

Takeda and AstraZeneca together hit Hetero labs Ltd.

COPD, or chronic obstructive pulmonary disease, is a progressive disease that makes it hard to breathe. "Progressive" indicates that the disease gets worse over time. COPD can cause coughing that produces large amounts of mucus, wheezing, shortness of breath, chest tightness, and other symptoms. Cigarette smoking is the leading cause of COPD. Most people who [...]

By |2017-09-08T17:51:13+05:30November 18th, 2016|Patent|0 Comments

Oracle sued the search giant for infringement

Can a programming language be infringed? Oracle has filed an infringement suit against Google for using JAVA language for their Android mobile operating system. The case is all about whether it is a violation of copy right or not. Java programming language’s application programming interface (API). An API is basically a set of instructions [...]

By |2017-09-08T17:52:47+05:30November 18th, 2016|IP Basics|0 Comments
Go to Top